FREE WHITE PAPER | PUBLISHED IN PARTNERSHIP WITH FIERCEBIOTECH
The New R&D Playbook: Accelerating Discovery Through Smarter Partnerships
Biopharma R&D teams face mounting pressure to compress discovery timelines while managing costs and maintaining compliance. Published in partnership with FierceBiotech, this white paper explores how technology-enabled supplier management is transforming the traditional outsourcing model—delivering speed, transparency, and access to innovation through smarter workflows.
Download Your Copy
Are your scientists spending more time managing suppliers than advancing research?
The traditional approach to R&D outsourcing—fragmented, project-by-project supplier engagement—creates operational bottlenecks that slow discovery and increase risk. With only 12% of clinical trial compounds reaching FDA approval and R&D costs exceeding $3.5 billion per novel drug, operational efficiency is no longer optional.
This white paper reveals how leading biopharma organizations are closing capacity gaps and accelerating time to IND through centralized, technology-enabled supplier management.
Inside This White Paper
The R&D Capacity Gap
How internal constraints and ad hoc outsourcing create bottlenecks that delay candidate progression and extend timelines to IND filing.
The Cost of Fragmentation
Why traditional outsourcing models result in compliance gaps, limited visibility, and operational overhead that undermines R&D effectiveness.
Technology-Enabled Supplier Management
How centralized platforms deliver 80%+ reductions in order-activation time while maintaining quality and compliance standards.
Strategic Partnership Framework
The operational and financial case for transforming supplier relationships from transactional arrangements to strategic collaborations.
Measuring What Matters
Outcome-based KPIs that track speed to IND, regulatory success, and scientific throughput—not just cost savings.